Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Ablation Pericarditis Reduction Study

NCT06731595 is registered in ClinicalTrials.gov with St. Vincent Cardiovascular Research Institute as lead sponsor.

NCT NCT06731595
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06731595 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Ablation Pericarditis Reduction Study
Lead sponsor
St. Vincent Cardiovascular Research Institute
Phase
Phase 2
Overall status
Completed
Start date
May 20, 2021
Completion date
October 1, 2022
Enrollment
248 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, catheter ablation, pericarditis